PHK
TEVA icon

Point72 Hong Kong’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Point72 Hong Kong’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5,162
Closed -$83.9K – 639
2024
Q2 		$83.9K Buy
+5,162
New +$79.5K 0.01% 344

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Point72 Hong Kong's TEVA Position: Q3 2024 in Review

Point72 Hong Kong sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q3 2024, closing a stake of 5,162 shares — an estimated $83.9K sold.

Point72 Hong Kong first reported a position in TEVA in Q2 2024 and held it in 1 quarter. The position peaked at $83.9K in Q2 2024. 543 funds tracked by Wall St. Rank hold TEVA as of Q3 2024.

  • Point72 Hong Kong reported no remaining Teva Pharmaceutical Industries Limited position as of Q3 2024 after selling out during the quarter.
  • Point72 Hong Kong sold 5,162 Teva Pharmaceutical Industries Limited shares in Q3 2024, an estimated $83.9K.
  • Point72 Hong Kong first reported a position in Teva Pharmaceutical Industries Limited in Q2 2024 and held it in 1 quarter.
  • Point72 Hong Kong's Teva Pharmaceutical Industries Limited position peaked at $83.9K in Q2 2024.
  • 543 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2024.

Based on Point72 Hong Kong's 13F filing for Q3 2024, filed 14 Nov 2024.